"We owe it to our nation's veterans and all Americans who are suffering from these conditions to evaluate these potential therapies with urgency, said FDA Commissioner Marty Makary."
"The recent moves on psychedelics reflect growing popular support for the mind-altering substances among Trump's supporters, including combat veterans and followers of the Make America Healthy Again movement."
"Calley Means, a former Kennedy campaign staffer now serving as a senior health adviser, has previously written about the 'mind-blowing' power of psychedelics and his plans to invest in companies developing the drugs."
"Democratic members of Congress have noted that vouchers have gone to companies that are politically favored by the White House, including those that have agreed."
President Trump signed an executive order to accelerate research on psychedelics, which remain illegal federally. The FDA awarded priority review vouchers to companies studying psilocybin for depression and methylone for PTSD. These vouchers aim to shorten review times significantly. The push for psychedelics reflects increasing support among Trump's base, including veterans. Health Secretary Robert F. Kennedy Jr. has advocated for making these substances available for psychiatric conditions. The FDA's actions may lead to renewed scrutiny of its drug review processes.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]